| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| S-227928 | S227928; S-227928 | Phase 2 Clinical | Les Laboratoires Servier | Hematologic Neoplasms; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute | Details |
| Influenza A M1 vaccine (Pascal Biosciences) | Phase 1 Clinical | Pascal Biosciences | Influenza A virus infections | Details | |
| adenovector based vaccine (Pascal Biosciences/University of British Columbia) | Phase 1 Clinical | Influenza A virus infections | Details | ||
| Bezetabart debotansine | STRO-001; SP7675; SP-7675; BN-301 | Phase 1 Clinical | Sutro Biopharma Inc | Lymphoma, B-Cell; Hematologic Neoplasms; Lymphoma, Large B-Cell, Diffuse; Multiple Myeloma; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin | Details |